72 related articles for article (PubMed ID: 12794432)
1. Platelet activating factor inhibition in sepsis: the end?
Rabinovici R
Crit Care Med; 2003 Jun; 31(6):1861-2. PubMed ID: 12794432
[No Abstract] [Full Text] [Related]
2. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
Schuster DP; Metzler M; Opal S; Lowry S; Balk R; Abraham E; Levy H; Slotman G; Coyne E; Souza S; Pribble J;
Crit Care Med; 2003 Jun; 31(6):1612-9. PubMed ID: 12794395
[TBL] [Abstract][Full Text] [Related]
3. Inflammation. A signal terminator.
Bazan NG
Nature; 1995 Apr; 374(6522):501-2. PubMed ID: 7700374
[No Abstract] [Full Text] [Related]
4. Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase.
Prescott SM
J Investig Allergol Clin Immunol; 1997; 7(5):416. PubMed ID: 9416565
[No Abstract] [Full Text] [Related]
5. Should we continue to target the platelet-activating factor pathway in septic patients?
Minneci PC; Deans KJ; Banks SM; Eichacker PQ; Natanson C
Crit Care Med; 2004 Feb; 32(2):585-8. PubMed ID: 14758184
[No Abstract] [Full Text] [Related]
6. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions].
Kawamura Y; Satoh K; Takamatsu S; Mizuno S
Rinsho Byori; 1987 Oct; 35(10):1149-53. PubMed ID: 3437547
[No Abstract] [Full Text] [Related]
7. Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states.
Nadel JA
J Clin Invest; 1996 Jun; 97(12):2689-90. PubMed ID: 8675676
[No Abstract] [Full Text] [Related]
8. Association of platelet-activating factor with primary acquired cold urticaria.
Grandel KE; Farr RS; Wanderer AA; Eisenstadt TC; Wasserman SI
N Engl J Med; 1985 Aug; 313(7):405-9. PubMed ID: 2410790
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses.
Henig NR; Aitken ML; Liu MC; Yu AS; Henderson WR
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):523-7. PubMed ID: 10934081
[TBL] [Abstract][Full Text] [Related]
10. The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS).
Braquet P; Hosford D
Prog Clin Biol Res; 1989; 308():425-39. PubMed ID: 2675060
[No Abstract] [Full Text] [Related]
11. The prevention of necrotizing enterocolitis. The role of platelet-activating factor acetylhydrolase.
Muguruma K; Furukawa M; Tjoelker LW; Dietsch G; Gray PW; Zhao B; Johnston JM
Adv Exp Med Biol; 1996; 416():129-33. PubMed ID: 9131138
[No Abstract] [Full Text] [Related]
12. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis.
Hemmings R; Miron P; Falcone T; Bourque J; Lepage N; Langlais J
Obstet Gynecol; 1993 Feb; 81(2):276-9. PubMed ID: 8423963
[TBL] [Abstract][Full Text] [Related]
13. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor acetylhydrolase and acute respiratory distress syndrome: unanswered questions.
Nakos G; Tsangaris I; Lekka ME
Crit Care Med; 2004 Jun; 32(6):1434-5; author reply 1435. PubMed ID: 15187544
[No Abstract] [Full Text] [Related]
15. Familial dilated cardiomyopathy.
McKenna CJ; Ichihara S; Yamada Y; Yokota M
Circulation; 1999 Oct; 100(17):e87. PubMed ID: 10534480
[No Abstract] [Full Text] [Related]
16. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
Gill P; Jindal NL; Jagdis A; Vadas P
J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.
Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978
[TBL] [Abstract][Full Text] [Related]
18. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor.
Farr RS; Wardlow ML; Cox CP; Meng KE; Greene DE
Fed Proc; 1983 Nov; 42(14):3120-2. PubMed ID: 6628702
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.
Tjoelker LW; Wilder C; Eberhardt C; Stafforini DM; Dietsch G; Schimpf B; Hooper S; Le Trong H; Cousens LS; Zimmerman GA; Yamada Y; McIntyre TM; Prescott SM; Gray PW
Nature; 1995 Apr; 374(6522):549-53. PubMed ID: 7700381
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice.
Kerek M; Akyurek N; Sozuer EM; Arar M; Muhtaroglu S
Hepatogastroenterology; 2003; 50(52):1097-100. PubMed ID: 12845989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
